So far, research focusing on NT-3 and NT-4 has focused on improving the understanding of these NTs and the possibility of their therapeutic use in demyelinating and neurodegenerative diseases, depression, and mood disorders [38]. This evidence concerns the gene NTF3 and depressive disorder.